S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
Urgent Warning (Ad)
Three Pullback Opportunities in Tech Right Now
Three Mid Caps Wall Street Sees Doubling Within 12 Months
Urgent Warning (Ad)
The Most Important Warren Buffett Stock for Investors: His Own
Dave & Buster’s Rebound Could Score for Investors 
A 100% Win Rate In 2022… (Ad)pixel
Micron Technology Goes on Breakout Watch
Judge orders US to resume oil lease sales in North Dakota
S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
Urgent Warning (Ad)
Three Pullback Opportunities in Tech Right Now
Three Mid Caps Wall Street Sees Doubling Within 12 Months
Urgent Warning (Ad)
The Most Important Warren Buffett Stock for Investors: His Own
Dave & Buster’s Rebound Could Score for Investors 
A 100% Win Rate In 2022… (Ad)pixel
Micron Technology Goes on Breakout Watch
Judge orders US to resume oil lease sales in North Dakota
S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
Urgent Warning (Ad)
Three Pullback Opportunities in Tech Right Now
Three Mid Caps Wall Street Sees Doubling Within 12 Months
Urgent Warning (Ad)
The Most Important Warren Buffett Stock for Investors: His Own
Dave & Buster’s Rebound Could Score for Investors 
A 100% Win Rate In 2022… (Ad)pixel
Micron Technology Goes on Breakout Watch
Judge orders US to resume oil lease sales in North Dakota
S&P 500   4,027.81
DOW   32,717.60
QQQ   312.72
3 Undervalued Dividend Payers For Volatile Market Conditions
Urgent Warning (Ad)
Three Pullback Opportunities in Tech Right Now
Three Mid Caps Wall Street Sees Doubling Within 12 Months
Urgent Warning (Ad)
The Most Important Warren Buffett Stock for Investors: His Own
Dave & Buster’s Rebound Could Score for Investors 
A 100% Win Rate In 2022… (Ad)pixel
Micron Technology Goes on Breakout Watch
Judge orders US to resume oil lease sales in North Dakota
Top-Rated Stocks  
NASDAQ:PLRX

Pliant Therapeutics - PLRX Insider Trading & Ownership

$27.15
+0.84 (+3.19%)
(As of 03/29/2023 12:00 AM ET)
Add
Compare
Today's Range
$26.48
▼
$27.53
50-Day Range
$21.94
▼
$36.26
52-Week Range
$3.96
▼
$36.64
Volume
278,597 shs
Average Volume
448,847 shs
Market Capitalization
$1.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$46.80

Pliant Therapeutics (NASDAQ:PLRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$8.75 M

PLRX Insider Buying and Selling by Quarter

Get PLRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pliant Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Pliant Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2023Bernard CoulieCEOSell15,000$33.61$504,150.00240,112  
1/31/2023Bernard CoulieCEOSell15,000$34.92$523,800.00240,112  
1/26/2023Bernard CoulieCEOSell15,000$35.29$529,350.00240,112  
1/24/2023Bernard CoulieCEOSell15,000$30.89$463,350.0093,812  
1/23/2023Eric LefebvreInsiderSell67,500$34.48$2,327,400.0076,926  
1/23/2023Keith Lamont CummingsCFOSell30,000$35.00$1,050,000.0084,424  
1/23/2023Mike OuimetteGeneral CounselSell20,000$34.19$683,800.005,947  
1/9/2023Bernard CoulieCEOSell5,000$19.17$95,850.0093,812  
1/6/2023Bernard CoulieCEOSell15,000$19.04$285,600.0093,812  
1/3/2023Bernard CoulieCEOSell15,000$19.33$289,950.0093,812  
12/22/2022Mike OuimetteGeneral CounselSell2,928$19.38$56,744.645,947  
12/20/2022Bernard CoulieCEOSell34,212$19.10$653,449.2093,812  
12/20/2022Eric LefebvreInsiderSell10,887$19.10$207,941.70144,426  
12/20/2022Keith Lamont CummingsCFOSell9,643$19.10$184,181.3080,424  
12/20/2022Mike OuimetteGeneral CounselSell4,719$19.10$90,132.908,875  
10/25/2022Eric LefebvreInsiderSell5,000$25.05$125,250.00133,437  
9/12/2022Bernard CoulieCEOSell12,502$22.54$281,795.0859,273  
7/11/2022Bernard CoulieCEOSell15,000$22.50$337,500.0059,273  
7/11/2022Eric LefebvreInsiderSell3,000$20.00$60,000.00138,436  
(Data available from 1/1/2013 forward)












PLRX Insider Trading Activity - Frequently Asked Questions

Who is on Pliant Therapeutics's Insider Roster?

The list of insiders at Pliant Therapeutics includes Bernard Coulie, Eric Lefebvre, Keith Lamont Cummings, and Mike Ouimette. Learn more on insiders at PLRX.

What percentage of Pliant Therapeutics stock is owned by insiders?

6.60% of Pliant Therapeutics stock is owned by insiders. Learn more on PLRX's insider holdings.

Which Pliant Therapeutics insiders have been selling company stock?

The following insiders have sold PLRX shares in the last 24 months: Bernard Coulie ($4,303,309.28), Eric Lefebvre ($3,081,466.70), Keith Lamont Cummings ($1,234,181.30), and Mike Ouimette ($830,677.54).

How much insider selling is happening at Pliant Therapeutics?

Insiders have sold a total of 333,891 Pliant Therapeutics shares in the last 24 months for a total of $9,449,634.82 sold.

This page (NASDAQ:PLRX) was last updated on 3/30/2023 by MarketBeat.com Staff